Development of in vivo confocal Raman spectroscopy (ICRS) methodology over the last 20 years has enabled previously unavailable capability to acquire molecular concentration gradients across the stratum corneum (SC), at the micron level and in a clinical setting. Professor Tony Rawlings has been a driving force in SC research for over 30 years, working with a wide range of teams across the world. Because a detailed knowledge of skin biochemistry was key to interpreting ICRS-acquired molecular concentration gradients, the authors formed a close working relationship with Professor Rawlings during the development of ICRS. This article, therefore, presents a summary of this process and how challenges raised by application of ICRS were tackled, towards the goal of validating the technique for clinical skin measurement.
{"title":"In vivo confocal Raman spectroscopy: The window into the skin","authors":"J. M. Crowther, P. J. Matts","doi":"10.1111/ics.12989","DOIUrl":"10.1111/ics.12989","url":null,"abstract":"<p>Development of in vivo confocal Raman spectroscopy (ICRS) methodology over the last 20 years has enabled previously unavailable capability to acquire molecular concentration gradients across the stratum corneum (SC), at the micron level and in a clinical setting. Professor Tony Rawlings has been a driving force in SC research for over 30 years, working with a wide range of teams across the world. Because a detailed knowledge of skin biochemistry was key to interpreting ICRS-acquired molecular concentration gradients, the authors formed a close working relationship with Professor Rawlings during the development of ICRS. This article, therefore, presents a summary of this process and how challenges raised by application of ICRS were tackled, towards the goal of validating the technique for clinical skin measurement.</p>","PeriodicalId":13936,"journal":{"name":"International Journal of Cosmetic Science","volume":"46 4","pages":"603-609"},"PeriodicalIF":2.7,"publicationDate":"2024-08-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141901619","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
<p>How many presentations by consultants who applied to your company can you remember? A very outstanding one, which was given more than 20 years ago, I remember exceptionally well. But what was so special or unique about it? Was it the quality of the lecture, its content or the person who gave it? I think it was simply everything together. This consultant was Anthony Vincent Rawlings, better known everywhere as “Tony”, someone whom Albert Kligman described in his last publication entitled “<i>Corneobiology and corneotherapy – a final chapter”</i> in IJCS in 2011 as the “indefatigable Master of the Masters.” I, on the other hand, simply called Tony “Mr. SC” or “the walking library.”</p><p>Fortunately, our company decided to take a chance on working with Tony. As it turned out, this was a wise decision. The business relationship lasted from 2002 to 2022, but our friendship still exists. Below are some of my more or less chronologically summarized memories of our long journey together.</p><p>I often wondered why Tony and I hadn't met earlier and when we met for the first time. It was probably at the IFSCC Conference in Platja d'Aro in 1993, where we both gave podium presentations. But somehow, we didn't really notice each other back then. It would be another 9 years before fate brought us together. The reason why Tony did not attend the Stratum corneum III Congress, which our company organized in Basel in 2001 together with Ronnie Marks and Jean-Luc Lévêque, was that Unilever's R&D department was once again being reorganized and Tony no longer wanted to move back from England to the USA with his young family. That was the moment he decided to start his own company, AVR Consulting, in 2002.</p><p>What a great time this Unilever SC gang, consisting of Tony, Clive Harding, Allan Watkinson and Ian Scott, had from the late 80s to the late 90s of the last century. How much light these extraordinary scientists shed on the SC, how many secrets they uncovered and unanswered questions they approached. It's unbelievable what these guys achieved in our field back then. We all still benefit from this today and build on many of these findings. I was envious of this special era more than once and often wished I could have been part of this group.</p><p>When the co-operation between our company and Tony began in 2002, two persons with similar scientific interests slowly came a little closer together. The time finally seemed ripe for us. For me, it was the beginning of something unique and wonderful. Tony and I were obsessed with understanding more about the key pathways in SC maturation and desquamation and the differences between different skin types, particularly on the face. We soon have developed the “Corneocare” concept as an umbrella for these processes. In the first phase of our collaboration, we focused on the serine proteases in the SC. It was a very fortunate circumstance that my colleagues in the Blood Coagulation Diagnostics Department at the time
{"title":"Memories of a two-decade journey with a SC addict","authors":"Rainer Voegeli","doi":"10.1111/ics.13011","DOIUrl":"10.1111/ics.13011","url":null,"abstract":"<p>How many presentations by consultants who applied to your company can you remember? A very outstanding one, which was given more than 20 years ago, I remember exceptionally well. But what was so special or unique about it? Was it the quality of the lecture, its content or the person who gave it? I think it was simply everything together. This consultant was Anthony Vincent Rawlings, better known everywhere as “Tony”, someone whom Albert Kligman described in his last publication entitled “<i>Corneobiology and corneotherapy – a final chapter”</i> in IJCS in 2011 as the “indefatigable Master of the Masters.” I, on the other hand, simply called Tony “Mr. SC” or “the walking library.”</p><p>Fortunately, our company decided to take a chance on working with Tony. As it turned out, this was a wise decision. The business relationship lasted from 2002 to 2022, but our friendship still exists. Below are some of my more or less chronologically summarized memories of our long journey together.</p><p>I often wondered why Tony and I hadn't met earlier and when we met for the first time. It was probably at the IFSCC Conference in Platja d'Aro in 1993, where we both gave podium presentations. But somehow, we didn't really notice each other back then. It would be another 9 years before fate brought us together. The reason why Tony did not attend the Stratum corneum III Congress, which our company organized in Basel in 2001 together with Ronnie Marks and Jean-Luc Lévêque, was that Unilever's R&D department was once again being reorganized and Tony no longer wanted to move back from England to the USA with his young family. That was the moment he decided to start his own company, AVR Consulting, in 2002.</p><p>What a great time this Unilever SC gang, consisting of Tony, Clive Harding, Allan Watkinson and Ian Scott, had from the late 80s to the late 90s of the last century. How much light these extraordinary scientists shed on the SC, how many secrets they uncovered and unanswered questions they approached. It's unbelievable what these guys achieved in our field back then. We all still benefit from this today and build on many of these findings. I was envious of this special era more than once and often wished I could have been part of this group.</p><p>When the co-operation between our company and Tony began in 2002, two persons with similar scientific interests slowly came a little closer together. The time finally seemed ripe for us. For me, it was the beginning of something unique and wonderful. Tony and I were obsessed with understanding more about the key pathways in SC maturation and desquamation and the differences between different skin types, particularly on the face. We soon have developed the “Corneocare” concept as an umbrella for these processes. In the first phase of our collaboration, we focused on the serine proteases in the SC. It was a very fortunate circumstance that my colleagues in the Blood Coagulation Diagnostics Department at the time ","PeriodicalId":13936,"journal":{"name":"International Journal of Cosmetic Science","volume":"46 4","pages":"484-487"},"PeriodicalIF":2.7,"publicationDate":"2024-08-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/ics.13011","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141901620","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}